This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hochholdinger, F.
Right arrow Articles by Überall, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hochholdinger, F.
Right arrow Articles by Überall, F.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, December 1999, p. 8052-8065, Vol. 19, No. 12
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Novel Membrane-Targeted ERK1 and ERK2 Chimeras Which Act as Dominant Negative, Isotype-Specific Mitogen-Activated Protein Kinase Inhibitors of Ras-Raf-Mediated Transcriptional Activation of c-fos in NIH 3T3 Cells

Franz Hochholdinger,1 Gottfried Baier,2 Anto Nogalo,1 Birgit Bauer,2 Hans H. Grunicke,1 and Florian Überall1,*

Institute of Medical Chemistry and Biochemistry1 and Institute of Medical Biology and Human Genetics,2 University of Innsbruck, A-6020 Innsbruck, Austria

Received 24 May 1999/Returned for modification 6 July 1999/Accepted 8 September 1999

Expression of constructs encoding fusion proteins of ERK1 and ERK2 containing a C-terminal farnesylation motif (CAAX) is predominantly localized at the cell membrane and was activated by coexpression of constitutively active Ha-RasL61 and epidermal growth factor. Both fusion proteins significantly inhibit the transcriptional activation of a c-fos-chloramphenicol acetyltransferase reporter induced by RasL61, constitutively active MEK1, or constitutively active RafBXB. The corresponding SAAX chimeras or overexpression of the wild-type ERKs did not interfere with the transcriptional activation of c-fos. The inhibition of the Ras-mediated c-fos induction by ERK2-CAAX can in part be rescued by coexpression of a wild-type ERK2 but not by wild-type ERK1. We find that ERK1-CAAX acts in the same fashion, indicating that mitogen-activated protein kinase (MAPK)-CAAX chimeras interact in an isotype-specific manner. It is demonstrated that both ERK1-CAAX and ERK2-CAAX associate with the corresponding endogenous ERKs, which explains the isotype-specific inhibitory effects of the ERK-CAAX chimeras. Evidence is presented that expression of ERK-CAAX fusion proteins inhibits the nuclear translocation of the corresponding endogenous ERKs. Disruption of MAPK translocation by membrane targeting provides additional, independent proof that nuclear translocation of ERKs is essential for the transcriptional activation of c-fos.


* Corresponding author. Mailing address: Institute of Medical Chemistry and Biochemistry, University of Innsbruck, Fritz Preglstr. 3, A-6020 Innsbruck, Austria. Phone: 43-512-507-3508. Fax: 43-512-507-2872. E-mail: Florian.Ueberall{at}uibk.ac.at.


Molecular and Cellular Biology, December 1999, p. 8052-8065, Vol. 19, No. 12
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Ma, C., Bower, K. A., Chen, G., Shi, X., Ke, Z.-J., Luo, J. (2008). Interaction between ERK and GSK3{beta} Mediates Basic Fibroblast Growth Factor-induced Apoptosis in SK-N-MC Neuroblastoma Cells. J. Biol. Chem. 283: 9248-9256 [Abstract] [Full Text]  
  • Diogon, M., Wissler, F., Quintin, S., Nagamatsu, Y., Sookhareea, S., Landmann, F., Hutter, H., Vitale, N., Labouesse, M. (2007). The RhoGAP RGA-2 and LET-502/ROCK achieve a balance of actomyosin-dependent forces in C. elegans epidermis to control morphogenesis. Development 134: 2469-2479 [Abstract] [Full Text]  
  • Glading, A., Koziol, J. A., Krueger, J., Ginsberg, M. H. (2007). PEA-15 Inhibits Tumor Cell Invasion by Binding to Extracellular Signal-Regulated Kinase 1/2. Cancer Res. 67: 1536-1544 [Abstract] [Full Text]  
  • Chen, J., Rusnak, M., Luedtke, R. R., Sidhu, A. (2004). D1 Dopamine Receptor Mediates Dopamine-induced Cytotoxicity via the ERK Signal Cascade. J. Biol. Chem. 279: 39317-39330 [Abstract] [Full Text]  
  • Ajenjo, N., Canon, E., Sanchez-Perez, I., Matallanas, D., Leon, J., Perona, R., Crespo, P. (2004). Subcellular Localization Determines the Protective Effects of Activated ERK2 against Distinct Apoptogenic Stimuli in Myeloid Leukemia Cells. J. Biol. Chem. 279: 32813-32823 [Abstract] [Full Text]  
  • Smith, E. R., Smedberg, J. L., Rula, M. E., Xu, X.-X. (2004). Regulation of Ras-MAPK pathway mitogenic activity by restricting nuclear entry of activated MAPK in endoderm differentiation of embryonic carcinoma and stem cells. JCB 164: 689-699 [Abstract] [Full Text]  
  • Chou, F.-L., Hill, J. M., Hsieh, J.-C., Pouyssegur, J., Brunet, A., Glading, A., Uberall, F., Ramos, J. W., Werner, M. H., Ginsberg, M. H. (2003). PEA-15 Binding to ERK1/2 MAPKs Is Required for Its Modulation of Integrin Activation. J. Biol. Chem. 278: 52587-52597 [Abstract] [Full Text]  
  • Habib, A. A., Chun, S. J., Neel, B. G., Vartanian, T. (2003). Increased Expression of Epidermal Growth Factor Receptor Induces Sequestration of Extracellular Signal-Related Kinases and Selective Attenuation of Specific Epidermal Growth Factor-Mediated Signal Transduction Pathways. Mol Cancer Res 1: 219-233 [Abstract] [Full Text]  
  • Kampfer, S., Windegger, M., Hochholdinger, F., Schwaiger, W., Pestell, R. G., Baier, G., Grunicke, H. H., Uberall, F. (2001). Protein Kinase C Isoforms Involved in the Transcriptional Activation of Cyclin D1 by Transforming Ha-Ras. J. Biol. Chem. 276: 42834-42842 [Abstract] [Full Text]  
  • Hanlon, M., Sturgill, T. W., Sealy, L. (2001). ERK2- and p90Rsk2-dependent Pathways Regulate the CCAAT/Enhancer-binding Protein-beta Interaction with Serum Response Factor. J. Biol. Chem. 276: 38449-38456 [Abstract] [Full Text]  
  • Le Roith, D., Zick, Y. (2001). Recent Advances in Our Understanding of Insulin Action and Insulin Resistance. Diabetes Care 24: 588-597 [Abstract] [Full Text]  
  • Eblen, S. T., Catling, A. D., Assanah, M. C., Weber, M. J. (2001). Biochemical and Biological Functions of the N-Terminal, Noncatalytic Domain of Extracellular Signal-Regulated Kinase 2. Mol. Cell. Biol. 21: 249-259 [Abstract] [Full Text]  
  • Lin, X., Nelson, P., Gelman, I. H. (2000). SSeCKS, a Major Protein Kinase C Substrate with Tumor Suppressor Activity, Regulates G1right-arrowS Progression by Controlling the Expression and Cellular Compartmentalization of Cyclin D. Mol. Cell. Biol. 20: 7259-7272 [Abstract] [Full Text]  
  • Glading, A., Uberall, F., Keyse, S. M., Lauffenburger, D. A., Wells, A. (2001). Membrane Proximal ERK Signaling Is Required for M-calpain Activation Downstream of Epidermal Growth Factor Receptor Signaling. J. Biol. Chem. 276: 23341-23348 [Abstract] [Full Text]  
  • Bauer, B., Krumbock, N., Fresser, F., Hochholdinger, F., Spitaler, M., Simm, A., Uberall, F., Schraven, B., Baier, G. (2001). Complex Formation and Cooperation of Protein Kinase Ctheta and Akt1/Protein Kinase Balpha in the NF-kappa B Transactivation Cascade in Jurkat T Cells. J. Biol. Chem. 276: 31627-31634 [Abstract] [Full Text]